Physician

Jonathan Buggey, MD

According to 2025 Medicare claims, Jonathan Buggey, MD (NPI: 1013250133) practices advanced heart failure and transplant cardiology in the Akron, OH market, with the plurality of this provider's patient population coming from Summit, OH. This provider's primary affiliated billing organization is SUMMA PHYSICIANS LLC (NPI: 1679742480; TIN: 34-1790929) and primary practice location at 44304-1619. Buggey is affiliated with the Summa Accountable Care Organization (ACO ID: A1063), participating under the MSSP model.

Buggey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 673 traditional Medicare patients, billed 1,089 HCPCS/CPT codes, and received $46,588 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 5,476 prescription claims across 545 beneficiaries totaling $4,728,095 in drug costs, led by Vyndamax (Tafamidis). DME data shows 47 claims. Open Payments data shows 5 records totaling $211. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $44,612 to $4,728,095. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	147	267	$16,153
2021	764	1,158	$48,546
2022	521	897	$47,641
2023	624	1,039	$47,585
2024	673	1,089	$46,588

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	95	715	$44,612
2016	81	842	$59,888
2017	22	86	$5,158
2018	22	94	$7,965
2019	26	178	$19,263
2020	33	92	$16,858
2021	185	1,109	$569,240
2022	306	2,809	$2,070,753
2023	442	4,270	$3,710,672
2024	545	5,476	$4,728,095

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	24	$1,319
2020	N/R	79	$5,477
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	47	$8,652

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	66	67	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	109	$78
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	159	159	$43
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	54	63	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	243	291	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	60	2,155	$1,593,120
Entresto	Sacubitril/Valsartan	351	26,214	$574,027
Eliquis	Apixaban	437	27,492	$520,323
Adempas	Riociguat	34	990	$455,187
Tyvaso Dpi	Treprostinil	15	420	$351,591

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	17	$6,162
J2260	Injection, milrinone lactate, 5 mg	N	N/R	14	$1,882
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	16	$607

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$211	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan Buggey, MD?

Tedicare shows public-source Medicare data for Jonathan Buggey, MD (NPI 1013250133), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Buggey, MD have ACO affiliation data?

Jonathan Buggey, MD is shown with ACO affiliation data for Summa Accountable Care Organization (MSSP, ACO ID A1063).

What billing organization is linked to Jonathan Buggey, MD?

Jonathan Buggey, MD is linked to SUMMA PHYSICIANS LLC (billing NPI 1679742480) in the available physician profile data.

Does Jonathan Buggey, MD have Open Payments data?

Jonathan Buggey, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.